{
    "nctId": "NCT03742908",
    "briefTitle": "Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients",
    "officialTitle": "A Single Center Prospective Randomized Control Trial Investigating the Short-term and Long-term Effects of Intraoperative Prophylactic Antibiotics/Antiseptics on Surgical Outcomes in Chinese Post-mastectomy Breast Reconstruction Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 291,
    "primaryOutcomeMeasure": "Occurrence of minor surgical site infection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who underwent mastectomy and eligible for implant-based breast reconstructions\n* Karnofsky Performance Status (KPS) larger than 70\n* No severe deficiency in hematological, cardiovascular system, no immunodeficiency, no severe abnormal liver or kidney function\n\nExclusion Criteria:\n\n* Metastatic breast cancer\n* Local or systemic infection within 30 days prior to breast reconstruction surgery\n* Local, oral or systemic administration of any form of antibiotics within 30 days prior to breast reconstruction surgery\n* Pre-operative complete blood count shows white blood cell (WBC) count \\>10\\*10\\^9/L, Neutrophil cell (N) count \\> 7.5\\*10\\^9/L or N%\\>80%\n* Pre-operative blood procalcitonin (PCT) higher than upper limit of the normal range\n* Past history with injection breast augmentation",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}